Turner Bruce

Immunome, Inc. · Chief Strategy Officer

Turner Bruce is listed in filings as Chief Strategy Officer at Immunome, Inc.. This profile follows SEC Form 4 activity through Aug 13, 2024, including 1 public disclosure. Recent filings connect the profile to Immunome, Inc. (IMNM). The current snapshot covers public activity from Aug 13, 2024. Reported amounts are shown as $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.